Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Mesoblast Limited
Mesoblast Ltd is engaged in the development of biologic products for the broad field of regenerative medicine. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells.
IPO Date: October 10, 2008
Sector: Healthcare
Industry: Biotech
Market Cap: $2.26B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.17 | 2.48%
Avg Daily Range (30 D): $0.24 | 1.40%
Avg Daily Range (90 D): $0.20 | 1.35%
Institutional Daily Volume
Avg Daily Volume: .14M
Avg Daily Volume (30 D): .25M
Avg Daily Volume (90 D): .23M
Trade Size
Avg Trade Size (Sh.): 143
Avg Trade Size (Sh.) (30 D): 71
Avg Trade Size (Sh.) (90 D): 78
Institutional Trades
Total Inst.Trades: 81
Avg Inst. Trade: $1.52M
Avg Inst. Trade (30 D): $1.98M
Avg Inst. Trade (90 D): $1.93M
Avg Inst. Trade Volume: .09M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.4M
Avg Closing Trade (30 D): $2.42M
Avg Closing Trade (90 D): $2.42M
Avg Closing Volume: 162.47K
   
News
Oct 19, 2025 @ 11:48 PM
Ryoncil® Net Revenues Increase 69% in Second Qu...
Source: Dr. Silviu Itescu
Oct 6, 2025 @ 11:24 PM
Ryoncil® Revenues Increase 66% in Second Quarte...
Source: Dr. Silviu Itescu
Sep 26, 2025 @ 5:49 AM
Mesoblast Cell Therapy Products are Designated U.S...
Source: Mesoblast Limited
Sep 15, 2025 @ 1:18 AM
Successful Commercial Launch of Ryoncil® Highli...
Source: Silviu Itescu
Sep 4, 2025 @ 1:47 AM
Mesoblast Enters Into Option To Issue US$50 Millio...
Source: Silviu Itescu
Splits
Jan 10, 2024:   1:2